Havens Advisors’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-47,500
Closed -$1.91M 50
2016
Q3
$1.91M Buy
+47,500
New +$1.17M 1.49% 19

Havens Advisors's CYNA Position: Q4 2016 in Review

Havens Advisors sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 47,500 shares — an estimated $1.91M sold.

Havens Advisors first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $1.91M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Havens Advisors reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Havens Advisors sold 47,500 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $1.91M.
  • Havens Advisors first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
  • Havens Advisors's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $1.91M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Havens Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.